Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Illustration: Sarah Grillo/Axios
Starboard Value, the activist hedge fund led by Jeffrey Smith, has taken a "relatively small" stake in CVS Health Corp. (NYSE: CVS), per the Wall Street Journal.
Why it matters: We don't know what Starboard wants from CVS, except that it isn't the status quo. Plus, this comes just weeks after reports that private equity is kicking the tire on CVS rival Walgreens, while Starboard just realized a win yesterday when eBay agreed to sell StubHub to Viagogo for $4 billion.
- Market reactions: CVS shares rose more than 1.7% on Monday, giving it a market cap of nearly $100 billion.
- The bottom line: "Starboard is one of the top activist-investment firms and its presence in a stock usually causes a company to sit up and take notice." — Corrie Driebusch, WSJ